PharmaBoardroom

Pierre Meulien – Executive Director, Innovative Medicines…

Dr Pierre Meulien, executive director of the Innovative Medicines Initiative (IMI), the world’s largest life science public-private partnership…

Gary Zieziula – President & Region Head North America,…

Gary Zieziula, president & region head North America for Kyowa Kirin, a specialty care-focused Japan-based global pharma company, highlights the…

COVID-19 / Lessons from MSD’s Ebola Vaccine Development:…

While outbreaks of the devastating Ebola virus have – thankfully – generally been highly localized to West Africa, the highly infectious and…

China: The Pharma Deals Keep Coming

The latest from Chinese pharma, with dealmaking continuing apace. Featured this week are Zai Lab’s latest IPO listing in Hong Kong, InventisBio…

Urs Vögeli – Managing Director, Janssen Switzerland

Urs Vögeli, managing director for Janssen Switzerland, outlines the importance of the Swiss operations to Janssen, his interesting career journey,…

Why Switzerland Needs a US FTA to Stop it ‘Falling Through the…

The USA is now Switzerland’s biggest export market and in 2019 Switzerland exported more to the US than to France, Italy, the UK and Austria…

UK-Japan FTA: Banishing UK Pharma’s Brexit Blues

The signing of an agreement on the terms of a future trade relationship between Japan and the UK has been welcomed by the UK pharma industry, which…

Has the Time Truly Come for Trudeau’s ‘National Pharmacare’…

As the only country in the world to boast a universal healthcare system that does not cover prescription drugs, Canada has been struggling with the…

Market Access in Switzerland: Reimbursement Delays for 76% of New…

Switzerland, rightly regarded as one of the world’s most innovative nations, risks damaging its reputation if innovative new medicines continue to…

US Elections: Biden & Trump’s Unworkable Drug Pricing…

In the aftermath of the fiery first presidential debate between incumbent Donald Trump and Democratic Party rival Joe Biden, we round up the latest on…

Karita Bekkemellem – Managing Director, LMI, Norway

Karita Bekkemellem of Norwegian pharma association LMI highlights her work building up the profile of the industry in Norway, the market access and…

Jan Børge Jakobsen – MD, Bayer Norway

Jan Børge Jakobsen, managing director of Bayer Norway, shares how he came to lead Bayer’s Norwegian affiliate after 30 years within the Norwegian…

Tagged with